We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets closed

Curaleaf Holdings, Inc. (CURLF)

Other OTC - Other OTC Delayed Price. Currency in USD
4.8300-0.4650 (-8.78%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close5.2950
Open5.1300
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range4.6900 - 5.2800
52 Week Range2.1900 - 5.9100
Volume704,184
Avg. Volume938,780
Market Cap3.573B
Beta (5Y Monthly)1.60
PE Ratio (TTM)N/A
EPS (TTM)-0.3200
Earnings DateMay 09, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CURLF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CURALEAF HOLDINGS INC
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more
  • InvestorPlace

    Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for April 2024

    Cannabis stocks could see higher highs. All thanks to recent legalization in Germany, the addition of a cannabis vote in Florida, growing approval ratings in polls, and speculation it could be favorably mentioned in the election. According to the Pew Research Center, about nine in 10 Americans (88%) said that cannabis should be legal for medical or recreational use. About 57% said cannabis should be legal for both medical and recreational use. About 32% said it should just be legal for medical u

  • PR Newswire

    Curaleaf to Report First Quarter 2024 Financial and Operational Results

    Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2024 after market close on May 9, 2024.

  • Business Wire

    Curaleaf International Comments As German Federal Cannabis Law Passes Without Delay

    LONDON, March 22, 2024--German Federal Government's cannabis law has successfully progressed without delay. Juan Martinez, Head of Curaleaf International, comments.

  • The Wall Street Journal

    Health Care Roundup: Market Talk

    Read about Dentalcorp, R1 RCM, Lonza and more in the latest Market Talks covering the Health Care sector.

  • InvestorPlace

    Wall Street’s Favorite Cannabis Stocks? 3 Names That Could Make You Filthy Rich

    If you’re looking for Wall Street’s favorite cannabis stocks, you’re most likely to find them amongst the holdings of the AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS), the largest U.S.-listed cannabis exchange traded fund (ETF). MSOS is an actively managed ETF with just under $1 billion in net assets. Its net assets are more than four times those of the next largest fund, Amplify Alternative Harvest ETF (NYSEARCA:MJ), with $243 million in net assets. If you’ve held MSOS since its launch in

  • CNW Group

    Curaleaf to Acquire Northern Green Canada to Bolster European Flower Supply

    Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced it has signed a deal to acquire Northern Green Canada ("NGC"), a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification. NGC also partners with Canadian GACP cultivators to produce and distribute finished cannabis products to both the domestic

  • Business Wire

    Curaleaf International Expands into Czech Republic with Astrasana Pharma Partnership

    LONDON, March 14, 2024--Curaleaf International, one of Europe's largest vertically integrated cannabis companies, is expanding into the Czech Republic.

  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Key Takeaways; Psychedelic Sector In a rollercoaster week for MSOs, the cannabis industry faced both triumphs and challenges. Despite many positive Q4 reports in late February, this week witnessed an unusual trend as only a few large MSO reported their financials. Surprisingly, the market responded with increased selling even after companies […]

  • CNW Group

    Curaleaf Reports Fourth Quarter and Full Year Ended 2023 Results

    Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results for the fourth quarter ended December 31, 2023. All financial information is reported in accordance with U.S. generally accepted accounting principles (GAAP) and is provided in U.S. dollars unless otherwise indicated.

  • InvestorPlace

    3 Cannabis Stocks Blazing a Trail to Legalization

    As excitement builds, U.S. federal agencies are looking to revise cannabis regulations. Support for cannabis legalization has surged to unprecedented levels, which bodes incredibly well for cannabis stocks. A Gallup survey in November last year revealed that a staggering 70% of Americans advocate for cannabis legalization, marking a historic high in public sentiment. This sentiment is further underscored by the wave of states legalizing cannabis for both recreational and medical purposes, along